Global Blood Therapeutics Inc entered the industry of Biological Research in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 541712, which describes it as a Biological Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Biological Research. The business provides service to the B2B market.
To acquire more information, please contact Mark A Goldsmith by calling (415) 766-3600 during business hours. You can also write to the business’ Single Location at 55 Mission St, San Francisco, California CA 94105. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Global Blood Therapeutics Inc |
Representative: | Mark A Goldsmith |
Place of Business: | 55 Mission St, San Francisco, CA 94105 |
Contact Number: | (415) 766-3600 |
Type of Service: | Biological Research |
SIC Number: | 8731 |
NAICS Number: | 541712 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2011 |
Income/Year: | $1.000.000 to $2.499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Global Blood Therapeutics Inc is a company operating from San Francisco, California providing professional Biological Research and relevant B2B variables. It was founded in 2011 and registered with the SIC code 8731 as Biological Research, and with the NAICS code 541712 as Biological Research.
With a current employee count of 1 to 4, Global Blood Therapeutics Inc has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Mark A Goldsmith at (415) 766-3600 for related queries, or to locate its Single Location using the coordinates 37.792901,-122.393389.
The Single Location can also be found at the street address 55 Mission St in San Francisco, California 94105 and can be engaged online through the company website at , the company Twitter , and Facebook page .